Prevalence of retinopathy in Caucasian type 2 diabetic patients from the South of Brazil and relationship with clinical and metabolic factors

Brazilian Journal of Medical and Biological Research

Volumn 38, Issue 2, 2005, Pages 221-225

  Santos, K G ^a   Tschiedel, B ^b   Schneider, J R ^b   Souto, K E P ^b   Roisenberg, I ^a  

^a FEDERAL UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

^b Grupo Hospitalar Conceicao   (Brazil)

Author keywords

Caucasian subjects; Diabetic retinopathy; Risk factors; Type 2 diabetes mellitus

Indexed keywords

ANTIHYPERTENSIVE AGENT; C PEPTIDE; GLYCOSYLATED HEMOGLOBIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ADULT; AGED; ARTICLE; BLOOD PRESSURE MEASUREMENT; BLOOD SAMPLING; BODY MASS; BRAZIL; CAUCASIAN; COMORBIDITY; CONFIDENCE INTERVAL; CONTROLLED STUDY; DIABETIC RETINOPATHY; DISEASE DURATION; FEMALE; GEOGRAPHIC DISTRIBUTION; HUMAN; HYPERTENSION; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; MULTIPLE REGRESSION; NON INSULIN DEPENDENT DIABETES MELLITUS; OPHTHALMOSCOPY; POPULATION DISTRIBUTION; POPULATION RESEARCH; PREVALENCE; PROTEINURIA; RISK ASSESSMENT; RISK FACTOR; SEX DIFFERENCE; SMOKING HABIT; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE;

EID: 14944376719     PISSN: 0100879X     EISSN: 1414431X     Source Type: Journal    
DOI: 10.1590/S0100-879X2005000200010     Document Type: Article

References (19)

1. Fong DS, Aiello L, Gardner TW, King GL, Blankenship G, Cavallerano JD, Ferris III FL & Klein R (2003). Diabetic retinopathy. Diabetes Care, 26 (Suppl I): S-99-S-102.
2. UK Prospective Diabetes Study Group (1998). Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet, 352: 837-853.
3. Stratton IM, Kohner EM, Aldington SJ, Turner RC, Holman RR, Manley SE & Matthews DR (2001). UKPDS 50: risk factors for incidence and progression of retinopathy in type II diabetes over 6 years from diagnosis. Diabetologia, 44: 156-163.
4. UK Prospective Diabetes Study Group (1998). Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. British Medical Journal 317: 703-713.
5. Lunetta M, Infantone L, Calogero AE & Infantone E (1998). Increased urinary albumin excretion is a marker of risk for retinopathy and coronary heart disease in patients with type 2 diabetes mellitus. Diabetes Research and Clinical Practice, 40: 45-51.
6. Liu DP, Molyneaux L, Chua E, Wang YZ, Wu CR, Jing H, Hu LN, Liu YJ, Xu ZR & Yue DK (2002). Retinopathy in a Chinese population with type 2 diabetes: factors affecting the presence of this complication at diagnosis of diabetes. Diabetes Research and Clinical Practice, 56: 125-131.
7. Foss MC, Paccola GMGF, Souza V & Iazigi N (1989). Analytic study of type 2 diabetic patients in a population sample from Ribeirão Preto area (São Paulo). Revista de Associação Médica Brasileira, 35: 179-183.
8. The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus (2000). Report of the expert committee on the diagnosis and classification of diabetes mellitus. Diabetes Care, 23 (Suppl I): S-4-S-19.
9. Anonymous (1997). The sixth report of the Joint National Committee on prevention, detection, evaluation, and treatment of high blood pressure. Archives of Internal Medicine, 157: 2413-2446.
10. Leske MC, Wu SY, Hyman L, Li X, Hennis A, Connell MAS & Schachat AP (1999). Diabetic retinopathy in a black population: the Barbados Eye Study. Ophthalmology, 106: 1893-1899.
11. Klein R, Klein BEK, Moss SE, Davis MD & DeMets DL (1989). The Wisconsin Epidemiologic Study of Diabetic Retinopathy X: four-year incidence and progression of diabetic retinopathy when age at diagnosis is 30 years or more. Archives of Ophthalmology, 107: 244-249.
12. Kalk WJ, Joannou J, Ntsepo S, Mahomed I, Mahanlal P & Becker PJ (1997). Ethnic differences in the clinical and laboratory associations with retinopathy in adult onset diabetes: studies in patients of African, European and Indian origins. Journal of Internal Medicine, 241: 31-37.
13. Florkowski CM, Scott RS, Moir CL & Graham PJ (1998). Clinical and biochemical outcomes of type 2 diabetes mellitus in Canterbury, New Zealand: a 6-year cohort study. Diabetes Research and Clinical Practice, 40: 167-173.
14. Kim HK, Kim CH, Kim SW, Park JY, Hong SK, Yoon YH & Lee KU (1998). Development and progression of diabetic retinopathy in Koreans with NIDDM. Diabetes Care, 21: 134-138.
15. West SK, Klein R, Rodriguez J, Muñoz B, Broman AT, Sanchez R & Snyder R (2001). Diabetes and diabetic retinopathy in a Mexican-American population: proyecto VER. Diabetes Care, 24: 1204-1209.
16. van Leiden HA, Dekker JM, Moll AC, Nijpels G, Heine RJ, Bouter LM, Stehouwer CD & Polak BC (2002). Blood pressure, lipids, and obesity are associated with retinopathy: the Hoorn study. Diabetes Care, 25: 1320-1325.
17. Yoshida Y, Hagura R, Hara Y, Sugasawa G & Akanuma Y (2001). Risk factors for the development of diabetic retinopathy in Japanese type 2 diabetic patients. Diabetes Research and Clinical Practice, 51: 195-203.
18. Savage S, Estacio RO, Jeffers B & Schrier RW (1996). Urinary albumin excretion as a predictor of diabetic retinopathy, neuropathy, and cardiovascular disease in NIDDM. Diabetes Care, 19: 1243-1248.
19. Klein R, Klein BEK, Moss SE, Davis MD & DeMets DL (1989). Is blood pressure a predictor of the incidence or progression of diabetic retinopathy? Archives of Internal Medicine, 149: 2427-2432.